Regimen Shows Potential for Reducing TLS Risk in CLL
Kerry Rogers, MD, discusses the feasibility of a new treatment for tumor lysis syndrome and what research still needs to be done with these agents in this patient population with chronic lymphocytic leukemia.
Source: OncLive